Colitis ulcerosa: vizsgálatok itt: Németország
39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Berlin, Brandenburg An Der Havel, Bremen, Dachau, Frankfurt Am Main, Kiel, Leipzig, Munich, Tuebingen, Ulm
- Életkor
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - 1. fázisBefejeződöttAn Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
- Where
- Berlin
- Életkor
- 18 év to 60 év
- People
- 25 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07665723 · EU 2025-524060-38-00 - 3. fázisTaking peopleA study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
- Where
- Aachen, Leipzig, Mainz, Tuebingen
- Életkor
- Up to 17 év
- People
- 68 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to join2024-511458-32-00 - 2. fázisTaking peopleA Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Where
- Brandenburg An Der Havel, Rostock, Ulm
- Életkor
- 18 év to 75 év
- People
- 100 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07463183 · EU 2025-523479-49-00 - 2. fázisFut, nem toborozAn Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
- Where
- Augsburg, Berlin, Brandenburg An Der Havel, Duisburg, Frankfurt Am Main, Halle (Saale), Hamburg, Hanover, Kiel, Munich, Remscheid, Ulm
- Életkor
- 18 év and over
- People
- 587 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2023-507853-13-00 - 2. fázisNot yet taking people in NémetországLong-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Berlin, Brandenburg An Der Havel, Bremen, Dachau, Frankfurt Am Main, Kiel, Leipzig, Munich, Tuebingen, Ulm
- Életkor
- 18 év and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00 - 1. fázisTaking peopleAn Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates
- Where
- Berlin, Cottbus, Munich, Ulm
- Életkor
- 18 év to 65 év
- People
- 25
- Run by
- Sanofi
See details and how to joinNCT07923383 · EU 2026-525939-17-00 - 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Frankfurt, Grevenbroich, Halle, Hanover, Leipzig, Potsdam
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 2. fázisTaking peopleLY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Where
- Berlin, Dachau, Erlangen, Regensburg, Ulm
- Életkor
- 18 év to 80 év
- People
- 252 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07186101 - 2. fázisTaking peopleA Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Where
- Berlin, Dachau, Halle (Saale), Ludwigshafen am Rhein, Ulm
- Életkor
- 18 év to 80 év
- People
- 60 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07483073 · EU 2025-524112-11-00 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Hamburg, Sankt Augustin
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - No phaseTaking peopleA Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 500
- Run by
- Janssen-Cilag G.m.b.H
See details and how to joinNCT07102368 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Berlin, Dachau, Dresden, Erlangen, Frankfurt Am Main, Halle (Saale), Halle Saale, Hanover, Jena, Kassel, Kiel, Leipzig, Mannheim, Munich, Regensburg, Rostock, Ulm
- Életkor
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00 - 4. fázisTaking peopleA study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
- Where
- Frankfurt
- People
- 16 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-522362-78-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Where
- Frankfurt Am Main, Regensburg
- Életkor
- 18 év and over
- People
- 224 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00 - 3. fázisTaking peopleA Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Where
- Cottbus, Erlangen, Kassel, Muenster, Potsdam
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00 - 2. fázisNot yet taking people in NémetországStudy of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Where
- Berlin, Dachau, Frankfurt Am Main, Freiburg im Breisgau, Halle (Saale), Hamburg, Hanover, Jerichow, Kiel, Leipzig, Ludwigshafen am Rhein, Luebeck, Lueneburg, Magdeburg, Mannheim, Pforzheim, Potsdam, Rostock, Ulm
- Életkor
- 18 év to 75 év
- People
- 2000 worldwide
- Run by
- AbbVie
See details and how to joinNCT07697456 · EU 2026-525959-86-00 - 2. fázisTaking peopleA Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- Where
- Leipzig, Muenster, Tuebingen, Wuppertal
- Életkor
- 2 év to 11 év
- People
- 24 worldwide
- Run by
- Pfizer
See details and how to joinNCT07470879 · EU 2025-523100-77-00 - 3. fázisTaking peopleAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Berlin, Halle, Herne, Kiel, Leipzig, Minden, Ulm, Wolfsburg
- Életkor
- 16 év to 80 év
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184996 - 2/3. fázisTaking peopleEfficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis
- Where
- Aachen, Augsburg, Bamberg, Berlin, Bremen, Cologne, Darmstadt, Dornstadt, Dresden, Frankfurt am Main, Frankfurt Am Main, Halle (Saale), Hamburg, Hamm, Hannover, Heidelberg, Kiel, Ludwigshafen am Rhein, Luebeck, Magdeburg, Mannheim, Muenster, Ulm
- Életkor
- 18 év to 80 év
- People
- 459
- Run by
- University Hospital Schleswig-Holstein
See details and how to joinNCT06488625 · EU 2024-510807-13-00 - No phaseTaking peopleStudy to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis
- Where
- Ahaus, Altenburg, Altenholz, Andernach, Berlin, Bochum, Buedelsdorf, Cologne, Dresden, Düsseldorf, Freiburg im Breisgau, Geesthacht, Halle, Hamburg, Hanover, Heide, Heidelberg, Herne, Jena, Jerichow, Karlsruhe, Kiel, Koblenz, Leipzig, Leverkusen, Lübeck, Ludwigshafen am Rhein, Magdeburg, Minden, Münster, Neumünster, Nordhausen, Pirmasens, Potsdam, Schwerin, Solingen, Teuchern, Tostedt, Wesseling, Witten, Wriezen, Würselen
- Életkor
- 18 év and over
- People
- 200
- Run by
- AbbVie
See details and how to joinNCT06764706 - 2/3. fázisTaking peopleA Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Where
- Dresden, Leipzig, München
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05076175 - 3. fázisTaking peopleA Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
- Where
- Aachen, Leipzig, Mainz, Tübingen
- Életkor
- 8 év to 18 év
- People
- 80 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to joinNCT06865417 - 3. fázisTaking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Berlin, Halle, Kiel, Leipzig, Minden, Tübingen, Ulm
- Életkor
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009 - 2. fázisTaking peopleLY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
- Where
- Berlin, Dachau, Erlangen, Regensburg, Ulm
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-522338-30-00